In Vitro Diagnostics (IVD) Market to Be Worth $87,207.9 Million by 2024 - Exclusive Report by Meticulous Research®

LONDON, July 24, 2019 (Newswire.com) - ​​​​Meticulous Research^® has published the latest market research report on a highly intriguing industry segment, “In Vitro Diagnostics (IVD)” in the past week. The report states that global In Vitro Diagnostic (IVD) market will increase at a CAGR of 5.7% from 2018 to reach $87,207.9 million by 2024, driven by a rising geriatric population and subsequent growth in the prevalence of chronic and infectious diseases, increasing adoption of fully-automated instruments and automation in laboratories, and growing adoption of personalized medicine and point-of-care testing.

Please download the report and learn more: https://www.meticulousresearch.com/download-sample-report/cp_id=4858

The report provides meticulous analysis of this market by segmenting it on the basis of product (reagents, instruments, and software & services), technique (immunoassay, clinical chemistry, molecular diagnostics, microbiology, hematology, coagulation & hemostasis, urinalysis, and other IVD technologies), application (polymerase chain reaction, isothermal nucleic acid amplification technology, microarray, hybridization, and DNA sequencing & next-generation sequencing), application (infectious diseases, diabetes, cancer/oncology, endocrinology, cardiology, nephrology, and others), end-user (hospital laboratories, independent reference laboratories, point-of-care testing, patient self-testing, and academic & research institutes), and geography (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa).

Geographically, North America commanded the largest share in this market followed by Europe. The major share of North America is mainly attributed to a remarkably advanced healthcare industry with higher healthcare spending; technological advancements in diagnostic tests; growing investments in personalized medicine; increasing prevalence of chronic diseases; and presence of leading players in the region.

“Despite North America being the largest market for IVD, it is the Asia Pacific region that registered the fastest growth rate majorly due to accelerated growth of economies; improving healthcare infrastructure; growing accessibility to healthcare services & advanced products; increasing incidence of infectious and non-communicable diseases with an aging population; growing income levels of middle-class population; and an increasing number of hospitals and clinics!” said Uddhav Sable, Research Director at Meticulous Research^®.

Browse 239 market data tables and 42 figures spread through 301 pages and in-depth TOC on https://www.meticulousresearch.com/product/ivd-market

Among applications, the infectious diseases segment commanded the largest share in this market mostly due to the high volume of IVD tests performed for infectious diseases, a high incidence of various infectious diseases, and incessant technological advancements in the tests used for the detection of such diseases.

The key players analyzed in the global In Vitro Diagnostics (IVD) market are Roche Diagnostics (Switzerland), Danaher Corporation (U.S.), Abbott Laboratories (U.S.), Siemens Healthcare (Germany), and Thermo Fisher Scientific Inc. (U.S.). These companies are leading the market owing to strategic acquisitions and launch of innovative products, strong distribution and sales network, and strong growth strategies. Other key players in the global IVD market are Sysmex Corporation (Japan), bioMérieux S.A. (France), Becton, Dickinson and Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), DiaSorin S.p.A. (Italy), Qiagen N.V. (the Netherlands), and Agilent Technologies, Inc. (U.S.)

The report is available for purchase in electronic format with multiple license choices and sectional purchases, starting from $499 only.

Request Sample or Check for Discount: https://www.meticulousresearch.com/request-discount/cp_id=4858

Scope of the In vitro diagnostics market Report:

Market by Product:

• Reagents & Kits
• Instruments
• Software & Services

Market by Technique

• Immunoassay
  • Enzyme-Linked Immunosorbent Assay (ELISA)
    • Chemiluminescence Immunoassays
    • Fluorescence Immunoassays
    • Colorimetric Immunoassays
  • Radioimmunoassay
  • Rapid Tests
  • Western Blotting
  • Enzyme-Linked Immunospot Assays
• Clinical Chemistry
  • Metabolic Panel
  • Electrolyte Panel
  • Liver Panel
  • Lipid Profile
  • Renal Profile
  • Thyroid Function Panel
• Molecular Diagnostics
  • Polymerase Chain Reaction
  • Isothermal Nucleic Acid Amplification Technology
  • Microarray
  • Hybridization
  • DNA Sequencing & Next-Generation Sequencing
• Microbiology
• Hematology
• Coagulation and Hemostasis
• Urinalysis
• Other IVD Technologies

Market by Application:

• Infectious Diseases
• Diabetes
• Cancer/Oncology
• Endocrinology
• Cardiology
• Nephrology
• Others

Market by End User

• Hospitals Laboratories
• Independent Reference Laboratories
• Point-Of-Care Testing
• Patient Self-Testing
• Academic and Research Institutes

Market by Geography:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • Italy
  • France
  • U.K.
  • Spain
  • Rest of Europe (RoE)
• Asia-Pacific (APAC)
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of APAC (RoAPAC)
• Latin America
• Middle East & Africa

Please download the report and learn more:  https://www.meticulousresearch.com/download-sample-report/cp_id=4858

Source: Meticulous Market Research Pvt. Ltd.